Industry Briefs: Apr. 30, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.
Company News
AMRI has launched Smartsourcing sourcing options for its contract manufacturing and research services. Read More
AstraZeneca and The Medicines Company have entered into a global development and commercialization pact and have agreed to copromote Brilinta (ticagrelor), for treating acute ischaemic heart disease, in the United States. Read More
Baxter International has completed its purchase of Sigma International. Read More
Cetero Research has reached a final resolution with FDA over studies the company conducted in its Houston, Texas, bioanalytical laboratory between Apr. 1, 2005 through June 15, 2010. Read More
Covance and BML are expanding the companies’ jointly owned clinical-trial laboratory in Japan. Read More
GlaxoSmithKline and the University of Nottingham are collaborating to create a Center of Excellence for sustainable chemistry. Read More
Penn Pharma has invested in additional clinical and commercial packing capabilities. Read More
Teva has settled its patent-infringement litigation with Mylan in regards to Teva’s wakefulness product Nuvigil (armodafinil). Read More
Therapure has opened a custom biologics manufacturing facility. Read More
People News
AMRI has appointed Saravanakumar Dhakshinamoorthy as director of in vitro biology. Dhakshinamoorthy will report to Takeshi Yura, senior director of AMRI’s Singapore division. Read More
Watson Pharmaceuticals has announced changes in the company’s senior leadership. Read More
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
